Benzonatate Capsule
Product Images NDC 0615-8661

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 0615-8661). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Benzonatate 8661 1)

Chemical structure diagram of Benzonatate showing its molecular formula C30H53NO11, with structural components including aromatic ring and multiple ether and amine groups.*

FDA Label Image

Principal Display Panel (Benzonatate 8661 2)

Benzonatate Capsules USP 100 mg oral dosage form label. The label includes multiple barcodes, lot number 8661, and quantity 30. It is labeled for institutional use only and manufactured by CSPC-NBP Pharmaceutical for Rising with packaging by Vangard Labs, Glasgow, KY. Storage instructions and usage directions are also provided on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.